INS and type 2 diabetes mellitus: Understanding the role of sortilin’s alternatively spliced variants may bridge a critical gap in knowledge regarding glucose transporter mis-localization in insulin resistant mouse adipocytes and lead to novel targets for therapeutics in T2DM management.